Dai Chung

Nine new endowed chair recipients honored

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

By VUMC News and Communications

A new target for neuroblastoma

Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics.

Boosting sarcoma cell death

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.

Patient’s freak pancreas injury spurs rapid response

Macie Glover sprinted across the gym floor at school earlier this year, tripped and crashed into a wall. In a bizzare sequence of events, she hit her head and arm and scraped her knees as the force of the crash propelled her whole body arching backward into a crescent shape.

By Christina Echegaray

March 22, 2017

Blocking neuroblastoma cell growth

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths.

By Leigh MacMillan

January 24, 2017

Monroe Carell Jr. Children’s Hospital at Vanderbilt receives American College of Surgeons Level I trauma verification

The American College of Surgeons (ACS) Committee on Trauma has verified Monroe Carell Jr. Children’s Hospital at Vanderbilt as a Level I pediatric trauma center, recognizing the hospital’s commitment to provide the highest level of care for injured pediatric patients.